1997European Journal of DermatologyRequires access

Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment

Peter C.M. van de Kerkhof, Carine J. M. van der Vleuten, M. Gerritsen, Conrad P. Glade, Thomas Anton Luger, T. Werfel, B. Klüss

Open publisher page 20 citations

Abstract

Vitamin D3 analogues represent a major innovation in the treatment of psoriasis today [1-4]. During the last 5 years, calcipotriol (50 µg/g) ointment has become a first line therapy for this condition. Calcipotriol treatment is generally accepted for long-term management of psoriasis, although irritation of the skin has been experienced by 25% of the patients and required discontinuation of treatment in approximately 6% of the [...]

About this research paper

What this paper is about

Vitamin D3 analogues represent a major innovation in the treatment of psoriasis today [1-4]. During the last 5 years, calcipotriol (50 µg/g) ointment has become a first line therapy for this condition. Calcipotriol treatment is generally accepted for long-term management of psoriasis, although irritation of the skin has been experienced by 25% of the patients and required discontinuation of treatment in approximately 6% of the [...]

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Vitamin D3 analogues represent a major innovation in the treatment of psoriasis today [1-4]. During the last 5 years, calcipotriol (50 µg/g) ointment has become a first line therapy for this condition. Calcipotriol treatment is generally accepted for long-term management of psoriasis, although irritation of the skin has been experienced by 25% of the patients and required discontinuation of treatment in approximately 6% of the [...]

Key concepts: Medicine, Calcipotriol, Psoriasis, Discontinuation, Dermatology, Plaque psoriasis, Irritation, Skin irritation

Related papers

Back to paper searchBrowse research topicsOriginal source
Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment — Research Paper | ScholarLens